The estimated Net Worth of Heyward R Donigan is at least $8.98 Миллион dollars as of 22 December 2021. Ms. Donigan owns over 14,350 units of Rite Aid stock worth over $363,674 and over the last 8 years she sold RAD stock worth over $0. In addition, she makes $8,619,340 as President, Chief Executive Officer и Director at Rite Aid.
Sign up
Ms. Donigan RAD stock SEC Form 4 insiders trading
Heyward has made over 2 trades of the Rite Aid stock since 2017, according to the Form 4 filled with the SEC. Most recently she bought 14,350 units of RAD stock worth $199,896 on 22 December 2021.
The largest trade she's ever made was buying 14,350 units of Rite Aid stock on 22 December 2021 worth over $199,896. On average, Heyward trades about 1,195 units every 114 days since 2016. As of 22 December 2021 she still owns at least 559,498 units of Rite Aid stock.
You can see the complete history of Ms. Donigan stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Heyward Donigan biography
Heyward R. Donigan serves as President, Chief Executive Officer, Director of the Company. She most recently served as the president and chief executive officer of Sapphire Digital. Prior to joining Sapphire Digital in 2015, Ms. Donigan was the president and chief executive officer of Valueoptions, Inc. beginning in 2010. Earlier in her career, Ms. Donigan served as executive vice president and chief marketing officer at Premera Blue Cross, and served as senior vice president of all operations at Cigna Healthcare. She also held executive roles at General Electric, Empire BCBS and U.S. Healthcare, and previously served on the Board of Directors at several public companies, including Kindred Healthcare. Ms. Donigan earned a Masters of Public Administration from New York University and a bachelor’s degree in English from the University of Virginia. Ms. Donigan currently serves on the board of directors of SI-Bone, Inc., and previously served on the boards of directors of NxStage Medical, Inc. from 2016 to 2019 and Kindred Healthcare, Inc. from 2014 to 2018. The Board has selected Ms. Donigan to serve as the new chief executive officer and as a member of the Board because of her broad experience with general management, strategic planning, technology, product, operations, compliance and marketing/sales background, and her consistent track record of organic, profitable growth across a broad spectrum of the healthcare industry.
What is the salary of Heyward Donigan?
As the President, Chief Executive Officer и Director of Rite Aid, the total compensation of Heyward Donigan at Rite Aid is $8,619,340. There are no executives at Rite Aid getting paid more.
What's Heyward Donigan's mailing address?
Heyward's mailing address filed with the SEC is C/O RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL, PA, 17011.
Insiders trading at Rite Aid
Over the last 45 years, insiders at Rite Aid have traded over $704,219,544 worth of Rite Aid stock and bought 1,989,612 units worth $9,286,101 . The most active insiders traders include Coutu Group (Pjc) Inc. Jean, John M Baumer и Equity Investors Iii Lpgei .... On average, Rite Aid executives and independent directors trade stock every 238 days with the average trade being worth of $2,811,488. The most recent stock trade was executed by Heyward R Donigan on 22 December 2021, trading 14,350 units of RAD stock currently worth $199,896.
What does Rite Aid do?
riteaid is a company based out of 7189 henry clay blvd, liverpool, new york, united states.
What does Rite Aid's logo look like?
Complete history of Ms. Donigan stock trades at Rite Aid и SI-BONE Inc
Rite Aid executives and stock owners
Rite Aid executives and other stock owners filed with the SEC include:
-
Heyward Donigan,
President, Chief Executive Officer, Director -
Heyward Rutledge Donigan B.A.,
Pres CEO & Director -
Jocelyn Konrad,
Executive Vice President - Pharmacy and Retail Operations -
Matthew Schroeder,
Chief Financial Officer, Senior Vice President -
James Peters,
Chief Operating Officer -
Jocelyn Zazyczny Konrad,
Exec. VP & Chief Pharmacy Officer -
James Joseph Peters Jr.,
Chief Operating Officer -
Matthew C. Schroeder,
CFO & Exec. VP -
Justin L. Mennen,
Exec. VP & Chief Information Officer -
Bruce Bodaken,
Independent Chairman of the Board -
Louis Miramontes,
Independent Director -
Arun Nayar,
Independent Director -
Kevin Lofton,
Independent Director -
Robert Knowling,
Independent Director -
Marcy Syms,
Independent Director -
Elizabeth Burr,
Independent Director -
Katherine Quinn,
Independent Director -
Bari Harlam,
Independent Director -
Paul Gilbert,
General Counsel, Company Secretary -
Brian Hoover,
Chief Accounting Officer -
Roxanne Schwans,
Senior Vice President - Market Access and Pharmacy Purchasing -
Angele Robinson-Gaylord,
Senior Vice President - Store Development -
Chris Bohrer,
Senior Vice President - Payor and Strategic Initiatives -
Trent Kruse,
Senior Vice President of Investor Relations, Treasury -
Erik Keptner,
Senior Vice President, Chief Marketing Officer -
Justin Mennen,
Senior Vice President, Chief Information Officer -
Andre Persaud,
Executive Vice President - Retail -
Susan K. Henderson,
Chief Communications Officer & Sr. VP -
Paul D. Gilbert,
Exec. VP, Gen. Counsel & Corp. Sec. -
Byron Purcell,
Sr. Director of Treasury Services & Investor Relations -
Brian T. Hoover,
Chief Accounting Officer & Sr. VP -
Michel Coutu,
Director -
James Donald,
Director -
Steven Bixler,
Chief Accounting Officer -
Bryan B Everett,
CHIEF OPERATING OFFICER -
Frank A Savage,
Director -
Michael N Regan,
Director -
Myrtle S Potter,
Director -
Joseph B Jr Anderson,
Director -
Castle Dedra Newman,
EVP -
David Jessick,
Director -
John T Standley,
Senior EVP & CAO -
David Abelman,
EVP -
Tony Montini,
EVP -
Darren W Karst,
EVP & CFO -
Kermit R Crawford,
President and COO -
Jessica Kazmaier,
EVP, Chief HR Officer -
James J Comitale,
EVP, General Counsel, Secy. -
Matt Schroeder,
EVP, Chief Financial Officer -
Derek S. Griffith,
Field EVP, Store Operations -
Benjamin Bulkley,
CEO EnvisionRXOptions -
Kenneth Martindale,
Senior Executive VP -
Andre Belzile,
Director -
Dennis Wood,
Director -
Philip G Satre,
Director -
Robert Gerald Miller,
Director -
Pierre Legault,
Senior EVP - CAO -
Equity Investors Iii Lpgree...,
-
Stuart M Sloan,
Director -
Douglas E Donley,
Senior VP and CAO -
Colin V Reed,
Director -
Robert Sari,
SVP AND GENERAL COUNSEL and -
Michael A Friedman,
Director -
Jonathan Ddanhakl John G So...,
-
George Golleher,
Director -
Robert J Easley,
Chief Operating Officer -
Mary F Sammons,
PRESIDENT & CEO -
Bruin Jerry Mark De,
EVP, Pharmacy -
Mark C Panzer,
SR. EVP - Store Operations -
Alfred Gleason,
Director -
Equity Investors Iii Lpgree...,
-
Kevin Twomey,
SVP & CHIEF ACCOUNTING OFFICER -
Robert A Mariano,
Director -
James P Mastrian,
SR.EVP.- Category Management -
Christopher Hall,
EVP and CFO -
Robert K Thompson,
EVP -
Robert Ivan Thompson,
EVP - Pharmacy -
Frank Vitrano,
Chief Admin. Officer & CFO -
Marc A Strassler,
EVP,General Counsel -
Coutu Group (Pjc) Inc. Jean,
10% owner -
Brian Fiala,
Executive VP, Operations -
Equity Investors Iii Lpgei ...,
-
John M Baumer,
Director -
Francois J Coutu,
Director -
Dan Robson,
President, EnvisionRXOptions -
Ray Smithberger,
SVP, Operations